Ballentine Partners, LLC Gsk PLC Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$42.05 - $47.77 $226,607 - $257,432	-5,389 Reduced 20.41%	21,021 $915,000
Q1 2022 May 05, 2022	BUY	$40.23 - $47.74 $215,109 - $255,265	5,347 Added 25.39%	26,410 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $101,321 - $118,077	2,606 Added 14.12%	21,063 $929,000
Q3 2021 Oct 27, 2021	BUY	$38.79 - $43.16 $132,002 - $146,873	3,403 Added 22.61%	18,457 $706,000
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $12,197 - $13,847	334 Added 2.27%	15,054 $600,000
Q1 2021 May 11, 2021	SELL	$34.27 - $40.01 $90,301 - $105,426	-2,635 Reduced 15.18%	14,720 $525,000
Q4 2020 Jan 25, 2021	BUY	$34.07 - $39.94 $9,982 - $11,702	293 Added 1.72%	17,355 $639,000
Q3 2020 Oct 22, 2020	SELL	$38.11 - $42.99 $16,958 - $19,130	-445 Reduced 2.54%	17,062 $642,000
Q2 2020 Jul 31, 2020	BUY	$37.87 - $43.58 $59,304 - $68,246	1,566 Added 9.82%	17,507 $714,000
Q1 2020 Apr 23, 2020	SELL	$32.47 - $48.83 $91,532 - $137,651	-2,819 Reduced 15.03%	15,941 $604,000
Q4 2019 Jan 22, 2020	BUY	$42.0 - $48.25 $32,592 - $37,442	776 Added 4.31%	18,760 $881,000
Q3 2019 Oct 21, 2019	BUY	$40.46 - $43.52 $3,560 - $3,829	88 Added 0.49%	17,984 $767,000
Q2 2019 Jul 25, 2019	SELL	$39.4 - $42.7 $7,486 - $8,113	-190 Reduced 1.05%	17,896 $716,000
Q1 2019 May 09, 2019	BUY	$38.57 - $42.69 $52,069 - $57,631	1,350 Added 8.07%	18,086 $756,000
Q4 2018 Feb 04, 2019	SELL	$37.8 - $42.69 $42,903 - $48,453	-1,135 Reduced 6.35%	16,736 $639,000
Q3 2018 Oct 30, 2018	BUY	$39.75 - $42.69 $10,494 - $11,270	264 Added 1.5%	17,871 $718,000
Q2 2018 Jul 19, 2018	BUY	$39.61 - $42.76 $211,398 - $228,210	5,337 Added 43.5%	17,607 $710,000
Q1 2018 Apr 26, 2018	BUY	$36.18 - $40.15 $50,688 - $56,250	1,401 Added 12.89%	12,270 $479,000
Q4 2017 Feb 02, 2018	BUY	$35.34 - $41.9 $24,950 - $29,581	706 Added 6.95%	10,869 $386,000
Q3 2017 Nov 06, 2017	BUY	$39.44 - $41.55 $400,828 - $422,272	10,163	10,163 $413,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account